Page last updated: 2024-08-25

cromakalim and luminol

cromakalim has been researched along with luminol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Al-Ayadhi, LY; Al-Tuwajri, AS	1

Other Studies

1 other study(ies) available for cromakalim and luminol

Article	Year
The synergistic effect of adenosine A2A receptors agonist, type IV phosphodiestease inhibitor and ATP-sensitive K channels activation on free radicals production and aggregation of human polymorphoneuclear leukocytes. Pharmacological research, 2004, Volume: 50, Issue:2 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Adenosine A2 Receptor Agonists; Cell Aggregation; Cell Survival; Cromakalim; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Drug Synergism; Free Radicals; Humans; Luminescent Measurements; Luminol; Neutrophils; Phenethylamines; Phosphodiesterase Inhibitors; Potassium Channels, Inwardly Rectifying; Reactive Oxygen Species; Receptor, Adenosine A2A; Respiratory Burst; Rolipram; Tetradecanoylphorbol Acetate	2004

Article

Year

The synergistic effect of adenosine A2A receptors agonist, type IV phosphodiestease inhibitor and ATP-sensitive K channels activation on free radicals production and aggregation of human polymorphoneuclear leukocytes.

Pharmacological research, 2004, Volume: 50, Issue:2

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Adenosine A2 Receptor Agonists; Cell Aggregation; Cell Survival; Cromakalim; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Drug Synergism; Free Radicals; Humans; Luminescent Measurements; Luminol; Neutrophils; Phenethylamines; Phosphodiesterase Inhibitors; Potassium Channels, Inwardly Rectifying; Reactive Oxygen Species; Receptor, Adenosine A2A; Respiratory Burst; Rolipram; Tetradecanoylphorbol Acetate

2004